Withdrawal notice to: ‘Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: A German database study’ [YBEOG 89C (2023) 102350]

Autor: Bielfeld, A.P., Schwarze, J.E., Verpillat, P., Lispi, M., Fischer, R., Hayward, B., Chuderland, D., D'Hooghe, T., Krussel, J.S.
Zdroj: In Best Practice & Research Clinical Obstetrics & Gynaecology July 2023 89
Databáze: ScienceDirect